SGLT2 Inhibitors in T2D with CKD

Share

Program Content

Activities

  • SGLT2i in T2D With CKD
    Role of SGLT2 Inhibitors in Type 2 Diabetes With Chronic Kidney Disease
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 12, 2022

    Expires: July 11, 2023

  • Slides: SGLT2i in T2D With CKD
    Role of SGLT2 Inhibitors in Type 2 Diabetes With Chronic Kidney Disease
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 12, 2022

    Expires: July 11, 2023

  • Commentary: SGLT2 Inhibitors in DKD
    Tips on Prescribing SGLT2 Inhibitors in Diabetic Kidney Disease
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 21, 2022

    Expires: July 20, 2023

Faculty

cover img faculity

Jennifer B. Green, MD

Professor of Medicine
Division of Endocrinology
Department of Medicine
Duke Clinical Research Institute
Duke University Medical Center
Durham, North Carolina

Provided by

ProCE Banner

Supporters

This activity is supported by independent educational grants from

Bayer HealthCare Pharmaceuticals Inc.

Boehringer Ingelheim and Eli Lilly